Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,533 | -32,968 | -142,623 | -136,214 | -95,248 |
| Depreciation Amortization | N/A | 114 | 1,876 | 1,763 | N/A |
| Accounts receivable | 1,082 | -1,928 | -8,789 | -2,602 | -5,868 |
| Accounts payable and accrued liabilities | 3,595 | -3,874 | -9,038 | -9,970 | -8,680 |
| Other Working Capital | 7,329 | -5,005 | -25,355 | -17,230 | -14,168 |
| Other Operating Activity | -3,990 | 13,951 | 42,755 | 54,202 | 43,543 |
| Operating Cash Flow | $-41,517 | $-29,710 | $-141,174 | $-110,051 | $-80,421 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -32 | -32 | 395 | -264 | -264 |
| Investing Cash Flow | $-32 | $-32 | $395 | $-264 | $-264 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 303 | 185 | 152,459 | 94,106 | 94,304 |
| Other Financing Activity | -985 | -768 | -1,514 | -250 | -250 |
| Financing Cash Flow | $-682 | $-583 | $150,945 | $93,856 | $94,054 |
| Exchange Rate Effect | N/A | -5 | 305 | 330 | 324 |
| Beginning Cash Position | 261,338 | 261,338 | 250,867 | 250,867 | 250,867 |
| End Cash Position | 219,107 | 231,008 | 261,338 | 234,738 | 264,560 |
| Net Cash Flow | $-42,231 | $-30,330 | $10,471 | $-16,129 | $13,693 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,517 | -29,710 | -141,174 | -110,051 | -80,421 |
| Capital Expenditure | -32 | -32 | -264 | -264 | -264 |
| Free Cash Flow | -41,549 | -29,742 | -141,438 | -110,315 | -80,685 |